Rize Oncology Inc.
RIZE
CNSX
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -14.78% | -29.04% | -28.07% | -25.36% | -24.06% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -35.94% | -45.75% | -47.98% | -86.36% | -68.15% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -15.49% | -30.10% | -29.86% | -25.77% | -27.43% |
|
|||||
Total Current Assets | -15.49% | -30.10% | -29.86% | -25.77% | -27.43% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -15.49% | -30.10% | -29.86% | -25.77% | -27.43% |
|
|||||
Total Accounts Payable | 152.22% | -2.97% | -40.05% | -44.04% | -50.31% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -51.43% | -- | -- | -- | -70.59% |
Total Other Current Liabilities | -51.43% | -- | -- | -- | -70.59% |
Total Current Liabilities | 115.28% | -2.97% | -40.05% | -44.04% | -55.84% |
|
|||||
Total Current Liabilities | 115.28% | -2.97% | -40.05% | -44.04% | -55.84% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 115.28% | -2.97% | -40.05% | -44.04% | -55.84% |
|
|||||
Common Stock & APIC | 0.45% | 4.83% | 3.45% | 3.99% | 3.15% |
Retained Earnings | -12.86% | -17.57% | -15.13% | -16.54% | -19.15% |
Treasury Stock & Other | 149.69% | -4.80% | -32.45% | 5.65% | 12.94% |
Total Common Equity | -19.17% | -30.67% | -29.60% | -24.64% | -26.09% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -19.17% | -30.67% | -29.60% | -24.64% | -26.09% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -19.17% | -30.67% | -29.60% | -24.64% | -26.09% |
|